Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A helping hand for dialysis: can coaching reduce the emotional toll?

NCT ID NCT07747012

Symptom relief Sponsor: Kutahya Health Sciences University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study tests whether a 6-week nurse-led self-management program can reduce dialysis-related distress in people receiving hemodialysis. The program includes weekly one-on-one sessions focusing on fluid control, diet, medication adherence, and coping with symptoms. Half of the 100 participants will receive the program alongside usual care, while the other half continues with usual care alone. The trial measures distress levels and treatment adherence at 6 and 18 weeks to see if the program makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured 6-week nurse-led needs-based dialysis self-management program, delivered through weekly face-to-face sessions covering education and individualized counseling on fluid, diet, medication, and symptom management.
What this could lead to
If effective, this program could offer a practical, non-drug way to ease the emotional burden of dialysis and improve treatment adherence.
What could go wrong
The trial is relatively small (100 participants) and single-center, so results may not apply broadly. The program's success depends on patient engagement and may not overcome all sources of distress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Receiving hemodialysis treatment for at least 3 months * Receiving hemodialysis treatment at least twice per week * Able to read and understand Turkish * Conscious and able to communicate * Providing written informed consent Exclusion Criteria: * Advanced cognitive impairment * Active psychiatric crisis * History of major surgery or acute severe illness within the last 3 months * Planned kidney transplantation in the near future * Serious physical or communication problems that may prevent regular participation in the intervention sessions * Concurrent participation in another structured education or psychosocial intervention program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dialysis-related distress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dialysis disequilibrium syndrome Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dialysis-related distress Hemodialysis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Simav Doc. Dr. Ismail Karakuyu State Hospital

    RECRUITING

    Simav, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.